These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26015210)

  • 1. [Serum uric acid reference values: clinical nonsense as a measure of quality].
    Löffler W
    MMW Fortschr Med; 2015 Apr; 157(6):57-8. PubMed ID: 26015210
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical findings and therapy of gout with special reference to the metabolic effects of sulfinpyrazone (Anturan) and allopurinol (Zyloric)].
    Günther R; Knapp E
    Wien Klin Wochenschr; 1969 Nov; 81(45):817-20. PubMed ID: 5362152
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of gout: beyond allopurinol.
    McGill NW
    Intern Med J; 2010 Aug; 40(8):545-53. PubMed ID: 20561096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on plasma protein binding of uric acid in gout].
    Holländer E
    Acta Med Acad Sci Hung; 1973; 30(4):241-9. PubMed ID: 4792224
    [No Abstract]   [Full Text] [Related]  

  • 5. Opportunities for improving medication use and monitoring in gout.
    Singh JA; Hodges JS; Asch SM
    Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current state of care in gout: Addressing the need for better understanding of an ancient disease.
    Zychowicz ME; Pope RS; Graser E
    J Am Acad Nurse Pract; 2010 Nov; 22 Suppl 1():623-36. PubMed ID: 21054636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout?
    Perez-Ruiz F; Lioté F
    Arthritis Rheum; 2007 Oct; 57(7):1324-8. PubMed ID: 17907217
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E; Schwarczmann P
    Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract]   [Full Text] [Related]  

  • 9. [Allopurinol and gouty hyperuricemia : apropos of 30 cases treated by a single daily dose].
    Appelboom T; Famaey JP
    Brux Med; 1977 Mar; 57(3):133-7. PubMed ID: 861817
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of allopurinol (Zyloric) on uric acid, creatinine, fasting blood sugar and plasma lipids in patients with gout].
    Günther R; Knapp E
    Wien Klin Wochenschr; 1970 Jan; 82(5):78-82. PubMed ID: 5513199
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative trial of azapropazone and indomethacin plus allopurinol in acute gout and hyperuricaemia.
    Fraser RC; Davis RH; Walker FS
    J R Coll Gen Pract; 1987 Sep; 37(302):409-11. PubMed ID: 3330140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma oxypurinol as a measure of adherence in clinical trials.
    Stamp LK; Merriman T; Frampton C; Zhang M; Wallace M; Miner JN; Dalbeth N
    Ann Rheum Dis; 2018 Feb; 77(2):313-314. PubMed ID: 28057666
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP
    Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of gout in surgical patients].
    Koch G; Schlosser GA
    Med Klin; 1968 Nov; 63(47):1897-9. PubMed ID: 5712110
    [No Abstract]   [Full Text] [Related]  

  • 15. [How to treat hyperuricemia and gout attacks in compensated kidney failure?].
    Gröbner W
    Dtsch Med Wochenschr; 2002 Mar; 127(11):576. PubMed ID: 11894180
    [No Abstract]   [Full Text] [Related]  

  • 16. Disease-specific noncompliance with drug treatment as a cause of persistent hyperuricemia and gout in anorexia nervosa.
    Gröbner W; Walter-Sack I; de Vries JX
    Eur J Med Res; 1998 Feb; 3(1-2):77-80. PubMed ID: 9512972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous measurement of plasma and erythrocyte oxypurines. II. Gouty patients with and without allopurinol medication.
    Hayashi TT; Gillo D; Turner JH; Rodnan GP
    Gynecol Invest; 1972; 3(5):221-36. PubMed ID: 4656975
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical aspects of chronic gout].
    Otto W; Binder E
    Z Gesamte Inn Med; 1966 Sep; 21(18):562-7. PubMed ID: 5990726
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of spironolactone and thiabutazide on serum-uric acid and lipid levels in patients with gout and in healthy persons].
    Mertz DP
    Dtsch Med Wochenschr; 1973 Jan; 98(1):11-5. PubMed ID: 4684940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.